Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Bogalusa Heart Study
© Mokha et al; licensee BioMed Central Ltd. 2010
Received: 13 April 2010
Accepted: 11 October 2010
Published: 11 October 2010
Body Mass Index (BMI) is widely used to assess the impact of obesity on cardiometabolic risk in children but it does not always relate to central obesity and varies with growth and maturation. Waist-to-Height Ratio (WHtR) is a relatively constant anthropometric index of abdominal obesity across different age, sex or racial groups. However, information is scant on the utility of WHtR in assessing the status of abdominal obesity and related cardiometabolic risk profile among normal weight and overweight/obese children, categorized according to the accepted BMI threshold values.
Cross-sectional cardiometabolic risk factor variables on 3091 black and white children (56% white, 50% male), 4-18 years of age were used. Based on the age-, race- and sex-specific percentiles of BMI, the children were classified as normal weight (5th - 85th percentiles) and overweight/obese (≥ 85th percentile). The risk profiles of each group based on the WHtR (<0.5, no central obesity versus ≥ 0.5, central obesity) were compared.
9.2% of the children in the normal weight group were centrally obese (WHtR ≥0.5) and 19.8% among the overweight/obese were not (WHtR < 0.5). On multivariate analysis the normal weight centrally obese children were 1.66, 2.01, 1.47 and 2.05 times more likely to have significant adverse levels of LDL cholesterol, HDL cholesterol, triglycerides and insulin, respectively. In addition to having a higher prevalence of parental history of type 2 diabetes mellitus, the normal weight central obesity group showed a significantly higher prevalence of metabolic syndrome (p < 0.0001). In the overweight/obese group, those without central obesity were 0.53 and 0.27 times less likely to have significant adverse levels of HDL cholesterol and HOMA-IR, respectively (p < 0.05), as compared to those with central obesity. These overweight/obese children without central obesity also showed significantly lower prevalence of parental history of hypertension (p = 0.002), type 2 diabetes mellitus (p = 0.03) and metabolic syndrome (p < 0.0001).
WHtR not only detects central obesity and related adverse cardiometabolic risk among normal weight children, but also identifies those without such conditions among the overweight/obese children, which has implications for pediatric primary care practice.
Childhood obesity is reaching epidemic proportions worldwide . Although childhood obesity is a well recognized risk factor for developing cardiovascular disease and type 2 diabetes mellitus in adulthood, excess central (intra-abdominal) body fat distribution may be more related to these diseases than peripheral distribution . Body Mass Index (BMI) is widely used as a measure to evaluate the impact of obesity on cardiovascular and metabolic risk factors, both in children and adults. However, in children, the BMI measures have to be expressed as z scores or percentiles relative to age and sex as BMI is strongly related to growth and maturation . Moreover, BMI does not always relate to central obesity  and it cannot differentiate muscle mass from bone and fat mass . Waist-to-Height Ratio (WHtR) has been proposed as an easily measurable anthropometric index for detection of central obesity and to assess associations between cardiometabolic risk factor variables and central intra-abdominal obesity [6–10]. Studies in adults have shown that it is possible to identify not only those with normal weight having an adverse cardiometabolic risk profile but also those with overweight/obese condition having normal metabolic risk profile [2, 5, 11]. Although studies relating BMI and WHtR to cardiovascular (CV) disease risk factors in children and adolescents are emerging [6, 12–17], information is scant on the utility of WHtR in assessing the status of abdominal obesity and related cardiometabolic risk profile among normal weight and overweight/obese children. The objective of this current study was to examine this aspect in children enrolled in the Bogalusa Heart Study, a biracial (black-white) community-based study of the natural history of CV disease since childhood .
The present study sample was derived from 3238 children, 4-18 years of age (mean age 10.98 years, 50% male, 56% white). After excluding those with age-, race- and sex-specific BMI less than the 5th percentile (n = 147), the subjects were divided into two groups: the normal weight group (n = 2581), with BMI between the 5th and the 85th percentiles; the overweight/obese group (n = 510), with BMI ≥ 85th percentile. Using the previously recommended cut-point [6, 8, 14], children in each group were sub-divided based on their WHtR: centrally obese (WHtR ≥ 0.5) or non-centrally obese (WHtR < 0.5). The protocols of this study were approved by the Institutional Review Board of the Tulane University Health Sciences Center. Informed consent was obtained from all the participants, for those under 18 years of age, consent of a parent/guardian was obtained.
Standardized protocols were used by trained examiners . The subjects were instructed to fast overnight before screening. Anthropometric and blood pressure measurements were made in replicate, and the mean values were used. The BMI was calculated as the weight in kilograms divided by the square of height in meters. Waist circumference was measured midway between the lowest border of rib cage and the upper border of iliac crest while the child was standing. Blood pressure measurements were obtained using a mercury sphygmomanometer, on the right arm of the participants who were in a relaxed sitting position, by two trained observers, each recording three measurements. The first and the fourth Korotkoff phases were recorded for systolic and diastolic blood pressures respectively, and average levels were used for analysis.
Serum cholesterol and triglyceride levels were assayed using enzymatic procedures (Abbott VP, North Chicago, Illinois) [20, 21]. The levels of lipoprotein cholesterol were analyzed by a combination of heparin-calcium precipitation and agar-agarose gel electrophoresis procedures . Plasma insulin measurements were obtained with the use of a commercial radio-immunoassay kit (Phadebas Insulin Kit; Pharmacia Diagnostics, Piscataway, NJ). Glucose was measured as part of a multiple chemistry profile (SMA 20) by a glucose oxidase method. The laboratory is monitored for precision and accuracy of lipid measurements by the Lipid Standardization and Surveillance Program of the Centers for Disease Control and Prevention (Atlanta, GA). Insulin resistance status was assessed as homeostasis model assessment of insulin resistance (HOMA-IR) according to the formula described : insulin (μU/mL) × glucose (mmol/L)/22.5.
All statistical analyses were performed using Statistical Analysis Systems, version 9.1 (SAS Institute, Cary, North Carolina). Continuous variables were tested for normality using the Kolmogorov-Smirnov test. The values of insulin and HOMA-IR were log transformed to improve the normality of distribution. The differences in the mean values (mean ± standard error) of the cardiometabolic risk factor variables between the sub-groups were tested separately for each of the two groups (normal weight and overweight/obese) by analysis of covariance, adjusting for age, race and sex wherever necessary. In multivariate analyses, independent associations between the cardiometabolic risk factor variables and central obesity were examined for both groups using separate multivariate logistic regression analysis models, taking the presence or absence of central obesity (yes/no) as the dependent variable. Adverse levels were defined as age-, race- and sex- specific top tertiles of each cardiometabolic risk variable (except for HDL cholesterol) and the lower two tertiles were used as the reference group; bottom tertile versus the rest for HDL cholesterol. Categorical variables and prevalence rates were compared using χ2 tests. With respect to metabolic syndrome, although there is a plethora of definitions used in studies of children, we used the one outlined by Cook et al .
Mean levels of cardiometabolic risk factor variables in normal weight and overweight/obese children by waist-to-height ratio: The Bogalusa Heart Study
NORMAL WEIGHT (BMI- 5th to 85th percentiles)#
OVERWEIGHT/OBESE (BMI ≥ 85th percentile)#
<0.5 (n = 2343)
≥0.5 (n = 238)
<0.5 (n = 101)
≥0.5 (n = 409)
Systolic Blood Pressure (mm Hg)
Diastolic Blood Pressure (mm Hg)
Mean Arterial Pressure (mm Hg)
LDL Cholesterol (mg/dl)
HDL Cholesterol (mg/dl)
Insulin Resistance Index (HOMA-IR)*
Odds Ratios and 95% CI for adverse levels of cardiometabolic risk factor variables in normal weight and overweight/obese children: The Bogalusa Heart Study.
NORMAL WEIGHT (n = 2581) (BMI- 5th to 85th percentiles)#(Referenced to waist-to-height ratio <0.5)
OVERWEIGHT/OBESE (n = 510) (BMI ≥ 85th percentile)#(Referenced to waist-to-height ratio ≥0.5)
Independent Variable (Top tertile vs. rest)*
Mean Arterial Pressure (mm Hg)
LDL Cholesterol (mg/dl)
HDL Cholesterol (mg/dl)
Insulin Resistance Index (HOMA-IR)
Prevalence of parental history of hypertension, cardiovascular disease and type 2 diabetes in normal weight and overweight/obese children by waist-to-height ratio: The Bogalusa Heart Study.
NORMAL WEIGHT (n = 2581) (BMI- 5th to 85th percentiles)#
OVERWEIGHT/OBESE (n = 510) (BMI ≥ 85th percentile)#
Parental history of hypertension
Parental history of cardiovascular disease
Parental history of type 2 diabetes mellitus
In this present cross-sectional, community-based study we used WHtR as a simple anthropometric index to identify the status of central (visceral) obesity and cardiometabolic risk factor profiles in groups of normal weight and overweight/obese children, selected based on traditional BMI criteria. Earlier studies in adults and children have supported the practicality of this convenient anthropometric index [6, 8, 10, 15–17]. We found that while the normal weight children with central obesity had adverse levels of cardiometabolic risk factor variables as compared to those without central obesity, the overweight/obese without central obesity had significantly lower levels in relation to those with central obesity. These observations in children are in accordance with the emerging concepts that recognize subsets of obesity and support the existence of metabolically obese normal weight, and metabolically benign obesity phenotypes in adults [2, 10, 11, 25]. These findings support the pathophysiologic role of intra-abdominal body fat distribution in determining interrelated cardiometabolic risk variables collectively recognized as metabolic syndrome [26–29]. It is now well recognized that central adiposity acts as a complex and highly active endocrine organ resulting in a variety of hormones and cytokines (tumor necrosis factor-α, interleukin-6 etc.), which in turn can play an important role in the dysregulation of inflammatory, metabolic and hemodynamic processes in the body through various mechanisms including hepatic lipogenesis and hepatic insulin resistance, release of free fatty acids from adipocytes, macrophage infiltration into the adipose tissue, adipose renin-angiotensin-aldosterone system and sympathetic nervous system activation and ectopic lipid storage [11, 30, 31].
Central obesity status regardless of normal weight or overweight/obesity condition in children is related to parental history of hypertension and type 2 diabetes, underscoring the familial nature of the relationship shown earlier in the Bogalusa Heart Study cohort [32, 33]. Even though the overweight/obese without central obesity had a lower prevalence of parental history of CV disease the difference did not reach the level of significance. This may be explained by the fact that our study subjects are children and the age of onset of CV disease is higher than that of type 2 diabetes mellitus.
We believe that the above mentioned observations have important public health implications. The traditional cut-offs for BMI may underestimate the cardiometabolic risk in the normal weight and overestimate the same in the overweight/obese children while WHtR may be more sensitive in identifying the children at risk, especially at a population level, and provide a better estimate of the overall risk. As normal weight children may have already developed central obesity, health awareness efforts must include such children and advocate lifestyle changes, which may be easier to achieve in this group, before they develop overt obesity and its complications.
This community-based study had certain limitations in that it lacked direct assessments of pubertal status, body fat mass and distribution and in vivo insulin action. Instead, we used well-established surrogate measures that are simple and appropriate at the population level. Furthermore, this study being observational and cross-sectional in nature, could not address the issue of causality.
The findings of the present study emphasize the utility of WHtR not only in detecting central intra-abdominal obesity and related cardiometabolic risk among normal weight children, but also in identifying those without central obesity and a healthy risk factor profiles among the overweight/obese children. Thus, WHtR has a potential for wider use as a simple measure to assess cardiometabolic risk in pediatric primary care practice.
List of Abbreviations
Body Mass Index
Low Density Lipoprotein
High Density Lipoprotein
Homeostasis Model of Assessment of Insulin Resistance
Mean Arterial Pressure
The Bogalusa Heart Study is a joint effort of many investigators and staff members, whose contributions are gratefully acknowledged. We especially thank the study participants, without whom this study would not be possible.
- Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA. 1999, 282: 1523-9. 10.1001/jama.282.16.1523.View ArticlePubMedGoogle Scholar
- Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU: Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008, 168: 1609-16. 10.1001/archinte.168.15.1609.View ArticlePubMedGoogle Scholar
- Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL: 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 112000. 2002, 1-190.Google Scholar
- Neovius M, Rasmussen F: Evaluation of BMI-based classification of adolescent overweight and obesity: choice of percentage body fat cutoffs exerts a large influence. The COMPASS study. Eur J Clin Nutr. 2008, 62: 1201-7. 10.1038/sj.ejcn.1602846.View ArticlePubMedGoogle Scholar
- Hall DM, Cole TJ: What use is the BMI?. Arch Dis Child. 2006, 91: 283-6. 10.1136/adc.2005.077339.View ArticlePubMedPubMed CentralGoogle Scholar
- Nambiar S, Hughes I, Davies PS: Developing waist-to-height ratio cut-offs to define overweight and obesity in children and adolescents. Public Health Nutr. 2010,Google Scholar
- Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J: Hazards of obesity-the Framingham experience. Atca Med Scand. 1988, 723 (Suppl): 23-36.Google Scholar
- Hsieh SD, Muto T: The superiority of waist-to-height ratio as an anthropometric index to evaluate clustering of coronary risk factors among non-obese men and women. Prev Med. 2005, 40: 216-20. 10.1016/j.ypmed.2004.05.025.View ArticlePubMedGoogle Scholar
- Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Müller MJ: Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes. 2006, 30: 475-83. 10.1038/sj.ijo.0803144.View ArticleGoogle Scholar
- Srinivasan SR, Wang R, Chen W, Wei CY, Xu J, Berenson GS: Utility of waist-to-height ratio in detecting central obesity and related adverse cardiovascular risk profile among normal weight younger adults (from the Bogalusa Heart Study). Am J Cardiol. 2009, 104: 721-4. 10.1016/j.amjcard.2009.04.037.View ArticlePubMedGoogle Scholar
- Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008, 168: 1617-24. 10.1001/archinte.168.15.1617.View ArticlePubMedGoogle Scholar
- Hara M, Saitou E, Iwata F, Okada T, Harada K: Waist-to-height ratio is the best predictor of cardiovascular disease risk factors in Japanese schoolchildren. J Atheroscler Thromb. 2002, 9: 127-32.View ArticlePubMedGoogle Scholar
- Maffeis C, Banzato C, Talamini G, Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology: Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr. 2008, 152: 207-13. 10.1016/j.jpeds.2007.09.021.View ArticlePubMedGoogle Scholar
- Goulding A, Taylor RW, Grant AM, Parnell WR, Wilson NC, Williams SM: Waist-to-height ratios in relation to BMI z-scores in three ethnic groups from a representative sample of New Zealand children aged 5-14 years. Int J Obes (Lond). 2010,Google Scholar
- Freedman DS, Kahn HS, Mei Z, Grummer-Strawn LM, Dietz WH, Srinivasan SR, Berenson GS: Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr. 2007, 86: 33-40.PubMedGoogle Scholar
- Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N, Georgiou C, Kafatos A: Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord. 2000, 24: 1453-8. 10.1038/sj.ijo.0801401.View ArticlePubMedGoogle Scholar
- Kahn HS, Imperatore G, Cheng YJ: A population-based comparison of BMI percentiles and waist-to-height ratio for identifying cardiovascular risk in youth. J Pediatr. 2005, 146: 482-8. 10.1016/j.jpeds.2004.12.028.View ArticlePubMedGoogle Scholar
- The Bogalusa Heart Study 20th anniversary symposium. Am J Med Sci. 1995, S1-S38. suppl 1
- Berenson GS, McMahan CA, Voors AW, Webber LS, Srinivasan SR, Frank GC, et al: Cardiovascular risk factors in children: the early natural history of athersclerosis and essential hypertension. 1980, New York: Oxford University PressGoogle Scholar
- Bucolo G, David H: Quantative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973, 19: 476-82.PubMedGoogle Scholar
- Srinivasan SR, Frerichs RR, Webber LS, Berenson GS: Serum lipoprotein profile in children from a biracial community. The Bogalusa Heart Study. Circulation. 1976, 54: 309-18.View ArticlePubMedGoogle Scholar
- Srinivasan SR, Berenson GS, Lewis LA, Opplt JJ: CRC Handbook of electrophoresis (lipoproteins). In: Serum lipoproteins in children and methods for study. 1983, Boca Raton (FL) CRC Press, 3: 185-203.Google Scholar
- Mathews DR, Hosker JP, Rudenski AS, Maylor BA, Trecher DF, Turner RC: Homeostatis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985, 28: 412-419. 10.1007/BF00280883.View ArticleGoogle Scholar
- Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003, 157: 821-7. 10.1001/archpedi.157.8.821.View ArticlePubMedGoogle Scholar
- Dvorak RV, DeNino WF, Ades PA, Poehlman ET: Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes. 1999, 48: 2210-4. 10.2337/diabetes.48.11.2210.View ArticlePubMedGoogle Scholar
- Nelson RA, Bremer AA: Insulin resistance and metabolic syndrome in the pediatric population. Metab Syndr Relat Disord. 2010, 8: 1-14. 10.1089/met.2009.0068.View ArticlePubMedGoogle Scholar
- Morrison JA, Friedman LA, Wang P, Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr. 2008, 152: 201-6. 10.1016/j.jpeds.2007.09.010.View ArticlePubMedGoogle Scholar
- Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009, 119: 628-47. 10.1161/CIRCULATIONAHA.108.191394.View ArticlePubMedGoogle Scholar
- Bao W, Srinivasan SR, Berenson GS: Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 1996, 93: 54-9.View ArticlePubMedGoogle Scholar
- Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P: Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008, 28: 1039-49. 10.1161/ATVBAHA.107.159228.View ArticlePubMedGoogle Scholar
- Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004, 89: 2548-56. 10.1210/jc.2004-0395.View ArticlePubMedGoogle Scholar
- Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS: Influence of childhood parental history of type 2 diabetes on the pre-diabetic and diabetic status in adulthood: the Bogalusa Heart Study. Eur J Epidemiol. 2009, 24: 537-9. 10.1007/s10654-009-9372-5.View ArticlePubMedGoogle Scholar
- McClain MR, Srinivasan SR, Chen W, Steinmann WC, Berenson GS: Risk of type 2 diabetes mellitus in young adults from a biracial community: the Bogalusa Heart Study. Prev Med. 2000, 31: 1-7. 10.1006/pmed.2000.0682.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2431/10/73/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.